Dr Champa Nataraja

Dr Champa Nataraja

Specialist in Rheumatology 

MBBS, FRACP, PhD

About

Dr Champa Nataraja is a consultant rheumatologist at Arthritis and Rheumatology centre, and Articulated Health and a physician-scientist.

Dr Nataraja graduated (MBBS) from Rajiv Gandhi University of Health Sciences, INDIA. She undertook basic physician training at the University Hospital Geelong, Victoria in 2015. She completed specialist training in Rheumatology at Monash Health and the Royal Hobart Hospital. She is a fellow of The Royal Australasian College of Rheumatology and a member of the Australian Rheumatology Association.

Dr Nataraja completed her PhD (Doctor of Philosophy) in 2020 from Monash University.

She has presented her research at the national and international conferences in Rheumatology.

Dr Nataraja has a special interest in inflammatory arthritis, musculoskeletal diseases, connective tissue diseases, osteoarthritis as well as complex rheumatic diseases. She aims to provide a high-quality medical service in rheumatology and care for her patients.

Outside of work, Dr Nataraja enjoys playing badminton and swimming.

    1. Nataraja, C., Morand, E., & Mak, A. (2025). 54 - Systemic glucocorticoid therapy for SLE. In D. J. Wallace, B. H. Hahn, A. Askanase, M. K. Crow, D. A. Isenberg, A. L. Cava, M. A. McMahon, B. P. Tsao, S. Venuturupalli, & M. H. Weisman (Eds.), Dubois' Lupus Erythematosus and Related Syndromes (Tenth Edition) (pp. 750–762). New Delhi: Elsevier.

    2. Nataraja C, Flynn J, Dankers W, Northcott M, Zhu W, Sherlock R, Bennett TJ, Russ BE, Miceli I, Pervin M, D'Cruz A, Harris J, Morand EF, Jones SA. GILZ regulates type I interferon release and sequesters STAT1. J Autoimmun. 2022 Jul;131:102858. doi: 10.1016/j.jaut.2022.102858. Epub 2022 Jul 8. PMID: 35810690.

    3. Nataraja, C., Zhu, W., Dankers, W., Jones, S.A. (2021). Balancing Strategies: GC and GILZ Axis. In: Hoi, A. (eds) Pathogenesis of Systemic Lupus Erythematosus. Springer, Cham. https://doi.org/10.1007/978-3-030-85161-3_10

    4. Nataraja, C., Dankers, W., Flynn, J., Lee, J., Zhu, W., Vincent, F. B., Gearing, L. J., Ooi, J., Pervin, M., Cristofaro, M. A., Sherlock, R., Hasnat, M. A., Harris, J., Morand, E. F., & Jones, S. A. (2021). GILZ Regulates the Expression of Pro-Inflammatory Cytokines and Protects Against End-Organ Damage in a Model of Lupus. Frontiers in Immunology, 12, 652800. https://doi.org/10.3389/fimmu.2021.652800

    5. Melissa Northcott., Linden J Gearing., Hieu T Nim., Champa Nataraja., Prof Paul Hertzog., Dr Sarah Jones., & Prof Eric Morand (2021). Glucocorticoid gene signatures in systemic lupus erythematosus and the effects of type I interferon: a cross-sectional and in-vitro study. The Lancet Rheumatology, Volume 3, Issue 5, 2021.

    6. Al-Heilfi A, Nataraja C, Cooley H, Batt T. Large-vessel vasculitis in graft-versus-host disease: a case report. J Med Case Rep. 2021 Sep 28;15(1):478. doi: 10.1186/s13256-021-03067-y. PMID: 34579779; PMCID: PMC8477472.

    7. Haiyin Liu, Kayla R. Wilson, Patrick Schriek, Christophe Macri, Annabelle B. Blum, Lauren Francis, Melanie Heinlein, Champa Nataraja, James Harris, Sarah A. Jones, Daniel H. D. Gray, Jose A. Villadangos, Justine D. Mintern (2020). Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4+ T Cells. The Journal of Immunology September 1, 2020, 205 (5) 1207–1216; DOI: 10.4049/jimmunol.1901328

    8. Nataraja, C., & Morand, E. (2018). Book Chapter 53, SYSTEMIC GLUCOCORTICOID THERAPY FOR SLE. Dubois' Lupus Erythematosus and Related Syndromes, 9e, Elsevier, 2018.

    9. Champa Nataraja and Hedley Griffiths, “Atypical Cutaneous Manifestations in Adult-Onset Still’s Disease,” Case Reports in Rheumatology, vol. 2016, Article.